These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23454100)

  • 1. Rapid determination of growth inhibition of Mycobacterium tuberculosis by GC-MS/MS quantitation of tuberculostearic acid.
    Cai G; Pauli GF; Wang Y; Jaki BU; Franzblau SG
    Tuberculosis (Edinb); 2013 May; 93(3):322-9. PubMed ID: 23454100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalable microparticles of nitric oxide donors induce phagosome maturation and kill Mycobacterium tuberculosis.
    Verma RK; Agrawal AK; Singh AK; Mohan M; Gupta A; Gupta P; Gupta UD; Misra A
    Tuberculosis (Edinb); 2013 Jul; 93(4):412-7. PubMed ID: 23562366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fast method for the identification of Mycobacterium tuberculosis in sputum and cultures based on thermally assisted hydrolysis and methylation followed by gas chromatography-mass spectrometry.
    Kaal E; Kolk AH; Kuijper S; Janssen HG
    J Chromatogr A; 2009 Aug; 1216(35):6319-25. PubMed ID: 19631943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy of piperine against Mycobacterium tuberculosis.
    Sharma S; Kalia NP; Suden P; Chauhan PS; Kumar M; Ram AB; Khajuria A; Bani S; Khan IA
    Tuberculosis (Edinb); 2014 Jul; 94(4):389-96. PubMed ID: 24880706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of pulmonary tuberculosis by detection of tuberculostearic acid in sputum by using gas chromatography-mass spectrometry with selected ion monitoring.
    French GL; Chan CY; Cheung SW; Oo KT
    J Infect Dis; 1987 Aug; 156(2):356-62. PubMed ID: 3598233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in rapid diagnosis of tuberculosis disease and anti-tuberculous drug resistance.
    Alcaide F; Coll P
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():34-40. PubMed ID: 21420565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Mycobacterium tuberculosis secretory serine protease blocks bacterial multiplication both in axenic culture and in human macrophages.
    Upadhye V; Majumdar A; Gomashe A; Joshi D; Gangane N; Thamke D; Mendiratta D; Harinath BC
    Scand J Infect Dis; 2009; 41(8):569-76. PubMed ID: 19479636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of the newly synthesised ER-2 against clinical isolates of Mycobacterium tuberculosis susceptible or resistant to antituberculosis drugs.
    Rao SS; Raghunathan R; Ekambaram R; Raghunathan M
    Int J Antimicrob Agents; 2009 Nov; 34(5):451-3. PubMed ID: 19625168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of conventional and radiometric methods for the assessment of anti-tubercular activity of drugs against Mycobacterium tuberculosis in mice and macrophage models.
    Jhamb SS; Singh RP; Singh PP
    Indian J Tuberc; 2008 Apr; 55(2):70-6. PubMed ID: 18516822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
    Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H
    Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of fatty acids in sputum from patients with pulmonary tuberculosis using gas chromatography-mass spectrometry preceded by solid-phase microextraction and post-derivatization on the fiber.
    Cha D; Cheng D; Liu M; Zeng Z; Hu X; Guan W
    J Chromatogr A; 2009 Feb; 1216(9):1450-7. PubMed ID: 19171347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid diagnosis of TB using GC-MS and chemometrics.
    Dang NA; Janssen HG; Kolk AH
    Bioanalysis; 2013 Dec; 5(24):3079-97. PubMed ID: 24320132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Course of murine tuberculosis and response to first-line therapy depends on route of infection and inoculum size.
    de Steenwinkel JE; ten Kate MT; de Knegt GJ; Verbrugh HA; van Belkum A; Hernandez-Pando R; Bakker-Woudenberg IA
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1478-84, i. PubMed ID: 22008760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug susceptibility of Mycobacterium tuberculosis to primary antitubercular drugs by nitrate reductase assay.
    Sethi S; Sharma S; Sharma SK; Meharwal SK; Jindal SK; Sharma M
    Indian J Med Res; 2004 Nov; 120(5):468-71. PubMed ID: 15591631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of IQG-607, a new orally active compound, in a murine model of Mycobacterium tuberculosis infection.
    Rodrigues-Junior VS; Dos Santos Junior A; Dos Santos AJ; Schneider CZ; Calixto JB; Sousa EH; de França Lopes LG; Souto AA; Basso LA; Santos DS; Campos MM
    Int J Antimicrob Agents; 2012 Aug; 40(2):182-5. PubMed ID: 22748570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid chemotaxonomic diagnosis of human tuberculosis.
    Yassin AF; Brzezinka H; Molitor E; Schaal KP
    Zentralbl Bakteriol; 1996 Jul; 284(2-3):466-73. PubMed ID: 8837405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of thiacetazone on mycobacterial species belonging to the Mycobacterium tuberculosis complex.
    Abate G; Koivula T; Hoffner SE
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):933-5. PubMed ID: 12365582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis.
    de Steenwinkel JE; de Knegt GJ; ten Kate MT; van Belkum A; Verbrugh HA; Kremer K; van Soolingen D; Bakker-Woudenberg IA
    J Antimicrob Chemother; 2010 Dec; 65(12):2582-9. PubMed ID: 20947621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
    Zanetti S; Sechi LA; Molicotti P; Cannas S; Bua A; Deriu A; Carta A; Paglietti G
    Int J Antimicrob Agents; 2005 Feb; 25(2):179-81. PubMed ID: 15664491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.